Indonesia’s pharma and healthcare sectors are among the most promising fields for investment. Backed by strong demographic trends, universal healthcare expansion, and supportive fiscal policy, foreign and domestic investors benefit from structured tax incentives, relaxed ownership restrictions, and growing demand for services and manufacturing capacity.
Also read: Why Indonesia Remains an Attractive Foreign Investment Destination in 2025
Market Potential: Why Invest in Indonesia’s Pharma and Healthcare?
Indonesia is home to the world’s largest national health insurance scheme—JKN-KIS—covering over 200 million people. This fuels predictable, long-term pharmaceutical demand. With increasing pressure to localize supply chains, Indonesia aims to shift from being a net importer to a manufacturing base for essential drugs, vaccines, and medical devices.
Domestic Production Over Imports
Generic drug consumption dominates due to affordability, creating an opportunity for scalable manufacturing. Industrial zones in East and West Java, Banten, and Sumatra are being optimized with enhanced utility infrastructure and logistics corridors.
Digital Healthcare and Infrastructure Gaps
Telemedicine, e-pharmacies, and AI-assisted diagnostics are rising due to fragmented access in rural regions. At the same time, Indonesia’s outdated hospital infrastructure has led to a USD 6 billion annual medical tourism outflow—now targeted for reversal via domestic facility expansion.
Strategic ASEAN Location
Indonesia’s archipelagic geography offers proximity to key ASEAN markets, encouraging regional pharma logistics hubs and cross-border partnerships.
Also read: Pharmaceutical Industry in Indonesia: Outlook and Opportunities
Applicable Incentives: Tax Holidays, KEK MedTech, and Ownership Reforms
Tax Holiday for Pharmaceutical Manufacturing
Eligibility:
Investments in “pioneer industries” like pharmaceutical manufacturing qualify for tax holidays up to 20 years under PMK No. 69/2024, extended through December 31, 2025.
Benefits:
- 100% Corporate Tax Exemption for up to 20 years based on capital outlay
- Additional 2-year tax reduction phase (50% discount post-holiday)
- Pioneer status includes sectors with high technology integration and economic impact
Regulatory Bodies:
- Ministry of Finance
- BKPM (Investment Coordinating Board)
- Ministry of Investment
Application Process:
Submit via the Online Single Submission (OSS) platform. Requirements include feasibility studies, fixed asset investment plan, and capital realization timelines.
Also read: Step-by-Step: How to Qualify for Tax Holiday in Indonesia
KEK MedTech and Special Economic Zones (SEZs)
Indonesia operates 14+ Kawasan Ekonomi Khusus (KEK)—Special Economic Zones—with unique fiscal and non-fiscal benefits. Pharma and MedTech investors can tap into tailored incentives through KEK MedTech-focused estates.
Key Benefits:
- Extended tax holidays (10–20 years depending on investment)
- PPN & import duty exemptions on medical equipment and raw materials
- 100% foreign ownership in designated subsectors
- Simplified immigration and customs handling
- Long-term land rights (up to 95 years)
Strategic KEKs for Pharma:
- Batam and Bintan: logistics access, digital R&D
- Sei Mangkei: chemical and bio-processing
- Java-focused KEKs: industrial clustering and low logistics cost
Also read: The Benefits of Investing in Indonesia’s Special Economic Zones (SEZs)
Hospital and Healthcare Facility Investments
100% Foreign Ownership Allowed
Thanks to GR 47/2021 under the Omnibus Law, foreign investors can now fully own and operate hospitals across Indonesia. Prior restrictions (67% for non-ASEAN, 75% for ASEAN) have been removed.
Key Provisions:
- Reduced bed minimums for new hospitals
- Mandatory provision of laboratory, blood bank, and nutrition services
- Risk-based licensing model to streamline registration
These policy changes support Indonesia’s goal of reducing medical tourism and upgrading its domestic healthcare system.
Also read: Risk-Based Business Licensing and OSS System in Indonesia
Other Relevant Incentives
Super Tax Deductions for R&D and Training
- 300% deduction for qualifying R&D activities
- 200% deduction for vocational training partnerships
- Particularly favorable for AI, biotech, and diagnostics development
Import Tax Reliefs
- PPN and customs exemptions for medical equipment and essential raw material imports
- Particularly beneficial for early-stage facility buildouts
Also read: Understanding Indonesia’s Super Deduction Tax for R&D and Training
Entry Strategy: How to Access the Market
Choose the Right KEK or Region
Align your business model with zone specialization. For pharma production, regions with gas pipeline access and logistics infrastructure (e.g., West Java, Banten) are ideal.
Leverage the OSS System
Use the Online Single Submission (OSS) portal to apply for:
- Investment registration
- Tax holidays/allowance
- Business and operational licenses
Partner with Local Institutions
Strategic alliances with Indonesian universities or R&D centers may increase eligibility for R&D super deductions and improve regulatory goodwill.
Regulatory Readiness
Prepare full documentation (feasibility study, DER compliance, KBLI classification, capital adequacy) to avoid delays and qualify for pioneer sector recognition.
Conclusion: Seizing the 2025 Window
With strong macroeconomic fundamentals, government commitment to healthcare reform, and comprehensive fiscal support, 2025 is a strategically favorable year to invest in Indonesia’s pharmaceutical and healthcare sectors. Those who move early to align with KEK MedTech zones and capitalize on extended tax holidays will be well-positioned for sustainable, high-yield operations in Southeast Asia’s most populous market.
If you are considering starting a business in Indonesia, there are a number of resources and support services available to help you get started.
InvestinAsia is among the companies that specialize in aiding you with Indonesia company registration. We boast a team of seasoned experts who can guide you throughout the process of:
- Foreign company / PMA registration in Indonesia
- Indonesia representative office registration
- PT PMDN Set Up
- Virtual office setup in Indonesia
- Business registration number in Indonesia
- Indonesian Business Licenses
- Indonesia Trademark Registration
- Indonesia Tax Consultant and Compliance Services
If you are interested in starting a business in Indonesia, you can start by contacting us for FREE consultation.
Frequently Asked Questions (FAQs)
What is the main incentive for pharma investors in Indonesia?
Eligible pioneer industries can benefit from a full exemption on corporate income tax for a period of up to 20 years through the tax holiday program.
Can foreign companies own hospitals in Indonesia?
Yes, since 2021, foreign investors have been permitted to fully own hospitals in Indonesia under Government Regulation No. 47/2021.
What is KEK MedTech?
KEK MedTech refers to specialized zones within Indonesia’s SEZ framework focused on medical technology, offering tax and operational incentives.
How do I apply for tax incentives?
All applications go through the OSS (Online Single Submission) system, overseen by BKPM and the Ministry of Investment.
What are the requirements to qualify for a tax holiday?
Investment size (min. Rp 500 billion), pioneer industry classification, Indonesian legal entity status, and timely realization of capital investment.
References:
